We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
-8.7%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
–
AUM
$394M
AUM Growth
-$61.6M
Cap. Flow
+$9.46M
Cap. Flow %
2.4%
Top 10 Hldgs %
41.57%
Holding
559
New
66
Increased
101
Reduced
108
Closed
35

Top Buys

Rank Stock Value
1
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$28.6M
2
BKT icon
BlackRock Income Trust
BKT
+$1.87M
3
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$1.66M
4
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$731K
5
FSLR icon
First Solar
FSLR
+$709K

Top Sells

Rank Stock Value
1
KBE icon
State Street SPDR S&P Bank ETF
KBE
+$5.14M
2
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$5.02M
3
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$3.44M
4
VRIG icon
Invesco Variable Rate Investment Grade ETF
VRIG
+$2.93M
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$2.78M

Sector Composition

Rank Sector Weight
1 Technology 9.05%
2 Healthcare 5.17%
3 Financials 4.79%
4 Utilities 4.37%
5 Energy 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTXN icon
351
First Trust Nasdaq Oil & Gas ETF
FTXN
$160M
$11K ﹤0.01%
485
– –
LQD icon
352
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$11K ﹤0.01%
103
– –
MKTX icon
353
MarketAxess Holdings
MKTX
$5.71B
$11K ﹤0.01%
43
– –
MYN icon
354
BlackRock MuniYield New York Quality Fund
MYN
$375M
$11K ﹤0.01%
1,000
– –
PCSA icon
355
Processa Pharmaceuticals
PCSA
$5.87M
$11K ﹤0.01%
+8
New +$11K
RCS
356
PIMCO Strategic Income Fund
RCS
$247M
$11K ﹤0.01%
2,132
– –
RYN icon
357
Rayonier
RYN
$6.6B
$11K ﹤0.01%
331
– –
VCNX
358
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$11K ﹤0.01%
48
– –
AB icon
359
AllianceBernstein
AB
$3.46B
$10K ﹤0.01%
229
+134
+141% +$5.63K
CSX icon
360
CSX Corp
CSX
$94.5B
$10K ﹤0.01%
360
-752
-68% -$24.5K
FIS icon
361
Fidelity National Information Services
FIS
$22.9B
$10K ﹤0.01%
108
+1
+0.9% +$99
IGLB icon
362
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.85B
$10K ﹤0.01%
186
– –
KHC icon
363
Kraft Heinz
KHC
$31.6B
$10K ﹤0.01%
272
+5
+2% +$200
MET icon
364
MetLife
MET
$61.9B
$10K ﹤0.01%
153
+1
+0.7% +$66
PYPL icon
365
PayPal
PYPL
$50.1B
$10K ﹤0.01%
141
– –
TROW icon
366
T. Rowe Price
TROW
$24.7B
$10K ﹤0.01%
90
+45
+100% +$5.72K
WEC icon
367
WEC Energy
WEC
$35.6B
$10K ﹤0.01%
100
– –
MRNS
368
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$10K ﹤0.01%
+2,000
New +$12.2K
MMP
369
DELISTED
Magellan Midstream Partners, L.P.
MMP
$10K ﹤0.01%
200
– –
ARCC icon
370
Ares Capital
ARCC
$14.1B
$9K ﹤0.01%
500
– –
BXMT icon
371
Blackstone Mortgage Trust
BXMT
$2.43B
$9K ﹤0.01%
309
– –
CIM
372
Chimera Investment
CIM
$1.06B
$9K ﹤0.01%
+333
New +$9.88K
CRM icon
373
Salesforce
CRM
$156B
$9K ﹤0.01%
53
+45
+563% +$7.95K
EPD icon
374
Enterprise Products Partners
EPD
$82.5B
$9K ﹤0.01%
350
– –
EPR icon
375
EPR Properties
EPR
$4.69B
$9K ﹤0.01%
200
– –
13 14
15
16 17

Similar funds

RC
RV Capital Schindellegi, Switzerland $383M AUM 21.52% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $383M AUM 17.99% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
RSS
Rosenblum Silverman Sutton San Francisco, California $382M AUM 13.82% 1-Year Est. Return
STP
Science & Technology Partners New York $382M AUM 202.26% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return

Vectors Research Management's Q2 2022 Portfolio in Review

As of Q2 2022, Vectors Research Management held 559 positions worth $394M, down 14% from $456M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Vectors Research Management's Q2 2022 filing shows 66 new, 101 increased, 108 reduced and 35 closed positions. Its largest new stake was Textron: 6,192 shares worth $378K. The largest sale was State Street SPDR S&P Bank ETF, an estimated $5.14M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.

  • Vectors Research Management's largest Q2 2022 buy was Textron: 6,192 shares worth $378K.
  • Vectors Research Management added most to Vanguard Morningstar Small-Cap ETF in Q2 2022, an estimated $28.6M increase.
  • Vectors Research Management's biggest Q2 2022 reduction was State Street SPDR S&P Bank ETF, cutting an estimated $5.14M.
  • Vectors Research Management fully exited Diageo in Q2 2022, selling an estimated $51K.
  • Vectors Research Management's ten largest holdings make up 42% of its $394M portfolio in Q2 2022.
  • Vectors Research Management opened 66 new positions and closed 35 in Q2 2022.
  • Vectors Research Management's portfolio value fell 14% quarter-over-quarter to $394M.

Based on Vectors Research Management's 13F filing for Q2 2022, filed 12 Aug 2022.